Rare diseases
Investigational molecules
Locations
Back to Portugal150 clinical trials in Vila Nova De Gaia, Portugal. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)Study on the Effectiveness and Safety of Ianalumab for Patients with Diffuse Cutaneous Systemic Sclerosis
PortugalStudy on the Effectiveness and Safety of Vedolizumab and Upadacitinib in Adults with Moderate to Severe Crohn's Disease
PortugalStudy on Frexalimab, SAR442970, and Rilzabrutinib for Patients Aged 16-75 with Focal Segmental Glomerulosclerosis or Minimal Change Disease
PortugalStudy Comparing OSE2101 and Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Immunotherapy Resistance
PortugalStudy on Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis and Suboptimal Response to Ruxolitinib
PortugalStudy on Long-Term Safety of Cenerimod for Adults with Moderate-to-Severe Systemic Lupus Erythematosus
PortugalStudy on VE303 for Preventing Recurrent C. difficile Infection in Patients
PortugalStudy on the Effects of Oseltamivir and Drug Combination for Patients with Pneumonia
PortugalStudy of apremilast compared to placebo in children aged 5-17 years with juvenile psoriatic arthritis
PortugalStudy Comparing MK-2870 and Pembrolizumab Combination to Pembrolizumab Alone for Patients with Metastatic Non-Small Cell Lung Cancer with High PD-L1 Levels
PortugalStudy Comparing MK-5684 with Abiraterone Acetate or Enzalutamide for Patients with Advanced Prostate Cancer After Hormonal Therapy
PortugalStudy Comparing Elranatamab to Drug Combinations for Patients with Relapsed/Refractory Multiple Myeloma After Anti-CD38 Therapy
PortugalThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on head and neck cancer, breast cancer, and multiple myeloma treatments. Studies include evaluations of novel therapies for both early-stage and metastatic conditions.
Research encompasses targeted therapies and combination treatments aimed at improving patient outcomes.
Comprehensive studies investigating treatments for various autoimmune conditions, including Sjögren's Syndrome and systemic sclerosis. Focus on developing targeted therapies for immune system regulation.
Evaluating novel biological therapies to address complex autoimmune manifestations.
Research focused on obesity management and cardiovascular health. Studies evaluate new therapeutic approaches for weight management and cardiovascular disease prevention.
Investigating innovative treatments to address growing metabolic health challenges.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
